Form D · Biotechnology
PROLUNG INC
Salt Lake City, UT · CIK 0001541884
Offering snapshot reported Dec 21, 2020 · SEC filing
- Reported sold
- $182K Offering amount: $6M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 3, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 21, 2020 | Initial | $182,000 | No comparison | 4 | SEC filing |
| Mar 16, 2018 | Initial | $824,000 | No comparison | 4 | SEC filing |
| May 8, 2017 | Amendment | $5,045,370 | $4,529,315vs Apr 8, 2016 | 160 | SEC filing |
| Apr 8, 2016 | Initial | $516,055 | No comparison | 11 | SEC filing |
| Nov 23, 2015 | Initial | $1,256,931 | No comparison | 2 | SEC filing |
| Feb 27, 2015 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-383794
Source: Form D, filed Dec 21, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Wayne Adams | Director |
| Mark V Anderson | Executive |
| Jared Bauer | Executive |
| Neil Berkley | Director |
| Clark A. Campbell | Director |
| Steven C Eror | Director, Executive |
| Michael A Garff | Executive |
| Jim Hogan | Director |
| Richard B. Mc Keown | Director |
| Garff Michael | Director, Executive |
| Todd M Morgan | Director |
| David Nielsen | Director |
| J. Scott Nixon | Director |
| J Scott Nixon | Director |
| Jeffrey S. O'driscoll | Director |
| Don Patterson | Director |
| Robert W Raybould | Director |
| John C Ruckdeschel | Director |
| Robin L Smith | Director |
| Aaron W Stout | Executive |
| Treu W. Tim | Director |
| Tim Treu | Director |
| Dennis Tulane | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
350 W. 800 N., Suite 214
Salt Lake City, UT, 84103
Salt Lake City, UT, 84103